JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease

M Nakamura, K Kimura, T Kimura, M Ishihara… - Circulation …, 2020 - jstage.jst.go.jp
In 2019, the Japanese Circulation Society published 2 guidelines in the field of coronary
artery disease (CAD):(1) a guideline for acute coronary syndrome (ACS) that integrated …

Utilization of artificial intelligence in echocardiography

K Kusunose, A Haga, T Abe, M Sata - Circulation Journal, 2019 - jstage.jst.go.jp
Echocardiography has a central role in the diagnosis and management of cardiovascular
disease. Precise and reliable echocardiographic assessment is required for clinical decision …

JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias

A Nogami, T Kurita, H Abe, K Ando, T Ishikawa… - Circulation …, 2021 - jstage.jst.go.jp
Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

JCS/JACR 2021 guideline on rehabilitation in patients with cardiovascular disease

S Makita, T Yasu, YJ Akashi, H Adachi, H Izawa… - Circulation …, 2022 - jstage.jst.go.jp
Eight years have passed since the publication of the only guideline on cardiac rehabilitation
(CR) in Japan,“Guidelines for rehabilitation in patients with cardiovascular disease (JCS …

JCS/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias

K Ono, Y Iwasaki, M Akao, T Ikeda, K Ishii… - Circulation …, 2022 - jstage.jst.go.jp
The Japanese Circulation Society (JCS) published the “Guidelines for Pharmacological
Treatment of Arrhythmia” in 2004, and a revised edition was published in 2009. 1 Both …

Comparative trends in percutaneous coronary intervention in Japan and the United States, 2013 to 2017

T Inohara, S Kohsaka, JA Spertus, FA Masoudi… - Journal of the American …, 2020 - jacc.org
Background Adoption of the results of large-scale randomized controlled trials in
percutaneous coronary intervention (PCI) may differ internationally, yet few studies have …

JCS/CVIT/JCC 2023 guideline focused update on diagnosis and treatment of vasospastic angina (coronary spastic angina) and coronary microvascular dysfunction

S Hokimoto, K Kaikita, S Yasuda, K Tsujita… - Circulation …, 2023 - jstage.jst.go.jp
In 2008, the Guidelines for diagnosis and treatment of patients with vasospastic angina
(coronary spastic angina) 1 were developed by the Japanese Circulation Society, and the …

Application of the academic research consortium high bleeding risk criteria in an all-comers registry of percutaneous coronary intervention

M Natsuaki, T Morimoto, H Shiomi… - Circulation …, 2019 - Am Heart Assoc
Background: Recently, the Academic Research Consortium for High Bleeding Risk (ARC-
HBR) has been proposed to standardize the definition of HBR, which was arbitrarily defined …

[HTML][HTML] Japanese Nationwide PCI (J-PCI) Registry Annual Report 2019: patient demographics and in-hospital outcomes

H Ando, K Yamaji, S Kohsaka, H Ishii, H Wada… - Cardiovascular …, 2022 - Springer
The Japanese Percutaneous Coronary Intervention (J-PCI) registry is endorsed by the
Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) and is …

[HTML][HTML] Current and novel antiplatelet therapies for the treatment of cardiovascular diseases

G Jourdi, M Lordkipanidze, A Philippe… - International journal of …, 2021 - mdpi.com
Over the last decades, antiplatelet agents, mainly aspirin and P2Y12 receptor antagonists,
have significantly reduced morbidity and mortality associated with arterial thrombosis. Their …